Moreover, as an anti-fibrinolysis agent, TXA inhibits the activity of plasmin, leading to the inhibition of pro-inflammatory factors, such as monocytes, neutrophils, platelet, endothelial cells, complement system and cytokines, which may reduce the risk of wound complications such as infection [12, 13]. Here, PLG is linked to infection.